Literature DB >> 7936655

Cloning and characterisation of the mouse fra-2 gene.

V C Foletta1, M H Sonobe, T Suzuki, T Endo, H Iba, D R Cohen.   

Abstract

Transcription factor AP-1 is comprised of multiple protein complexes that include members of a family of genes related to the proto-oncogene c-fos. In this report, we have extended the analysis of one member of this family, fos-related antigen-2 (fra-2), by isolating and characterising genomic and cDNA clones encoding the mouse fra-2 homolog. The overall gene structure (number and positions of introns) was similar to that of both the chicken fra-2 gene and other members of the fos family, and the relative positions of putative enhancers in the 5' regulatory region were well conserved between the mouse and chicken fra-2 genes. High levels of fra-2 mRNA were detected in ovary, stomach, small and large intestine, brain, lung and heart. The mouse Fra-2 protein showed 94% and 87.5% conservation with human and chicken Fra-2, respectively, and mouse Fra-2, like the chicken homolog, induced transformation of chicken embryo fibroblasts. The characterisation of the mouse fra-2 gene provides a basis for analysis of Fra-2 function in the whole animal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936655

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently.

Authors:  Matthew R Young; Rajalakshmi Nair; Natalie Bucheimer; Preety Tulsian; Nicole Brown; Cristi Chapp; Tin-Chen Hsu; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

2.  Nerve growth factor, but not epidermal growth factor, increases Fra-2 expression and alters Fra-2/JunD binding to AP-1 and CREB binding elements in pheochromocytoma (PC12) cells.

Authors:  V Boss; J D Roback; A N Young; L J Roback; D M Weisenhorn; R Medina-Flores; B H Wainer
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

3.  Fos-related antigen 2: potential mediator of the transcriptional activation in rat adrenal medulla evoked by repeated immobilization stress.

Authors:  B B Nankova; M Rivkin; M Kelz; E J Nestler; E L Sabban
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

4.  The gene encoding the Fos-related antigen 2 (Fosl2) maps to mouse chromosome 5.

Authors:  C Poirier; A Lalouette; V C Foletta; D R Cohen; J L Guénet
Journal:  Mamm Genome       Date:  1997-03       Impact factor: 2.957

5.  The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome.

Authors:  K W Ng; P Ridgway; D R Cohen; D J Tremethick
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

6.  Tissue-specific transgenic knockdown of Fos-related antigen 2 (Fra-2) expression mediated by dominant negative Fra-2.

Authors:  M Smith; Z Burke; A Humphries; T Wells; D Klein; D Carter; R Baler
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

7.  Transcriptional control of circadian hormone synthesis via the CREM feedback loop.

Authors:  N S Foulkes; J Borjigin; S H Snyder; P Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

8.  FOSL2 promotes leptin gene expression in human and mouse adipocytes.

Authors:  Christiane D Wrann; Jun Eguchi; Aline Bozec; Zhao Xu; Tarjei Mikkelsen; Jeffrey Gimble; Heike Nave; Erwin F Wagner; Shao-En Ong; Evan D Rosen
Journal:  J Clin Invest       Date:  2012-02-13       Impact factor: 14.808

9.  Restraint-induced fra-2 and c-fos expression in the rat forebrain: relationship to stress duration.

Authors:  M S Weinberg; M Girotti; R L Spencer
Journal:  Neuroscience       Date:  2007-09-14       Impact factor: 3.590

10.  Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells.

Authors:  Yuko Saeki; Takaho Endo; Kaori Ide; Takeshi Nagashima; Noriko Yumoto; Tetsuro Toyoda; Harukazu Suzuki; Yoshihide Hayashizaki; Yoshiyuki Sakaki; Mariko Okada-Hatakeyama
Journal:  BMC Genomics       Date:  2009-11-20       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.